Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


Oliena Studio

Stroke and language recovery: 9000+ videos

EspañolItalianoSarduEnglish | PDF+


  Ischemic Heart Disease

  Free Subscription


Articles published in JAMA

Retrieve available abstracts of 108 articles:
HTML format
Text format



Single Articles


    October 2019
  1. MORRIS NB, Gruss F, Lempert S, English T, et al
    A Preliminary Study of the Effect of Dousing and Foot Immersion on Cardiovascular and Thermal Responses to Extreme Heat.
    JAMA. 2019;322:1411-1413.
    PubMed     Text format    


  2. JAIN A, Davis AM
    Primary Prevention of Cardiovascular Disease.
    JAMA. 2019 Oct 4:1-3. doi: 10.1001/jama.2019.15915.
    PubMed     Text format    


    September 2019
  3. WEXLER DJ
    Sulfonylureas and Cardiovascular Safety: The Final Verdict?
    JAMA. 2019 Sep 19. pii: 2751396. doi: 10.1001/jama.2019.14533.
    PubMed     Text format    


  4. ROUMIE CL, Chipman J, Min JY, Hackstadt AJ, et al
    Association of Treatment With Metformin vs Sulfonylurea With Major Adverse Cardiovascular Events Among Patients With Diabetes and Reduced Kidney Function.
    JAMA. 2019 Sep 19:1-11. doi: 10.1001/jama.2019.13206.
    PubMed     Text format     Abstract available


  5. ROSENSTOCK J, Kahn SE, Johansen OE, Zinman B, et al
    Effect of Linagliptin vs Glimepiride on Major Adverse Cardiovascular Outcomes in Patients With Type 2 Diabetes: The CAROLINA Randomized Clinical Trial.
    JAMA. 2019 Sep 19. pii: 2751398. doi: 10.1001/jama.2019.13772.
    PubMed     Text format     Abstract available


  6. ABBASI J
    Cardiovascular Corner: Prescription Omega-3s, Stroke Rehab, and Statins After Age 75.
    JAMA. 2019 Sep 11. pii: 2751407. doi: 10.1001/jama.2019.14485.
    PubMed     Text format    


  7. FERENCE BA, Bhatt DL, Catapano AL, Packard CJ, et al
    Association of Genetic Variants Related to Combined Exposure to Lower Low-Density Lipoproteins and Lower Systolic Blood Pressure With Lifetime Risk of Cardiovascular Disease.
    JAMA. 2019 Sep 2. pii: 2749533. doi: 10.1001/jama.2019.14120.
    PubMed     Text format     Abstract available


  8. AMINIAN A, Zajichek A, Arterburn DE, Wolski KE, et al
    Association of Metabolic Surgery With Major Adverse Cardiovascular Outcomes in Patients With Type 2 Diabetes and Obesity.
    JAMA. 2019 Sep 2. pii: 2749478. doi: 10.1001/jama.2019.14231.
    PubMed     Text format     Abstract available


    August 2019
  9. DUNCAN MS, Freiberg MS, Greevy RA Jr, Kundu S, et al
    Association of Smoking Cessation With Subsequent Risk of Cardiovascular Disease.
    JAMA. 2019;322:642-650.
    PubMed     Text format     Abstract available


  10. COLE TB
    Smoking Cessation and Reduction of Cardiovascular Disease Risk.
    JAMA. 2019;322:651.
    PubMed     Text format    


  11. YANG WY, Melgarejo JD, Thijs L, Zhang ZY, et al
    Association of Office and Ambulatory Blood Pressure With Mortality and Cardiovascular Outcomes.
    JAMA. 2019;322:409-420.
    PubMed     Text format     Abstract available


  12. ZHONG VW, Van Horn L, Allen NB
    Dietary Cholesterol or Egg Consumption and Cardiovascular Outcomes-Reply.
    JAMA. 2019;322:467.
    PubMed     Text format    


  13. KEYSERLING TC, Berkowitz SA, Samuel-Hodge CD
    Dietary Cholesterol or Egg Consumption and Cardiovascular Outcomes.
    JAMA. 2019;322:466-467.
    PubMed     Text format    


    July 2019
  14. JAHAN R, Saver JL, Schwamm LH, Fonarow GC, et al
    Association Between Time to Treatment With Endovascular Reperfusion Therapy and Outcomes in Patients With Acute Ischemic Stroke Treated in Clinical Practice.
    JAMA. 2019;322:252-263.
    PubMed     Text format     Abstract available


    June 2019
  15. HAHN JY, Song YB, Oh JH, Chun WJ, et al
    Effect of P2Y12 Inhibitor Monotherapy vs Dual Antiplatelet Therapy on Cardiovascular Events in Patients Undergoing Percutaneous Coronary Intervention: The SMART-CHOICE Randomized Clinical Trial.
    JAMA. 2019;321:2428-2437.
    PubMed     Text format     Abstract available


  16. WATANABE H, Domei T, Morimoto T, Natsuaki M, et al
    Effect of 1-Month Dual Antiplatelet Therapy Followed by Clopidogrel vs 12-Month Dual Antiplatelet Therapy on Cardiovascular and Bleeding Events in Patients Receiving PCI: The STOPDAPT-2 Randomized Clinical Trial.
    JAMA. 2019;321:2414-2427.
    PubMed     Text format     Abstract available


  17. ABBASI J
    Cardiovascular Corner: Low Lipids, Metformin, and Plant-Based Diets.
    JAMA. 2019 Jun 12. pii: 2736162. doi: 10.1001/jama.2019.6544.
    PubMed     Text format    


  18. ZHENG SL, Roddick AJ
    Meta-analysis of Aspirin for Primary Prevention of Cardiovascular Events-Reply.
    JAMA. 2019;321:2244-2245.
    PubMed     Text format    


  19. SHAH R
    Meta-analysis of Aspirin for Primary Prevention of Cardiovascular Events.
    JAMA. 2019;321:2244.
    PubMed     Text format    


  20. SYN NL, Wee IJY
    Meta-analysis of Aspirin for Primary Prevention of Cardiovascular Events.
    JAMA. 2019;321:2243-2244.
    PubMed     Text format    


    May 2019
  21. BERRY C, McCartney PJ, Maznyczka AM
    Fibrinolytic Therapy to Reduce Microvascular Obstruction After Myocardial Infarction-Reply.
    JAMA. 2019;321:2033-2034.
    PubMed     Text format    


  22. ALKHALIL M
    Fibrinolytic Therapy to Reduce Microvascular Obstruction After Myocardial Infarction.
    JAMA. 2019;321:2032-2033.
    PubMed     Text format    


  23. SEZER M, Umman S
    Fibrinolytic Therapy to Reduce Microvascular Obstruction After Myocardial Infarction.
    JAMA. 2019;321:2032.
    PubMed     Text format    


  24. CHAN MTV, Wang CY, Seet E, Tam S, et al
    Association of Unrecognized Obstructive Sleep Apnea With Postoperative Cardiovascular Events in Patients Undergoing Major Noncardiac Surgery.
    JAMA. 2019;321:1788-1798.
    PubMed     Text format     Abstract available


  25. AUCKLEY D, Memtsoudis S
    Unrecognized Obstructive Sleep Apnea and Postoperative Cardiovascular Complications: A Wake-up Call.
    JAMA. 2019;321:1774-1776.
    PubMed     Text format    


  26. WISE RA, Chapman KR, Scirica BM, Bhatt DL, et al
    Effect of Aclidinium Bromide on Major Cardiovascular Events and Exacerbations in High-Risk Patients With Chronic Obstructive Pulmonary Disease: The ASCENT-COPD Randomized Clinical Trial.
    JAMA. 2019;321:1693-1701.
    PubMed     Text format     Abstract available



  27. Cardiovascular Benefits of SGLT2 Inhibitors and GLP-1 Receptor Agonists in Type 2 Diabetes.
    JAMA. 2019;321:1720-1721.
    PubMed     Text format    


    April 2019
  28. GREGG EW, Hora I, Benoit SR
    Resurgence in Diabetes-Related Complications.
    JAMA. 2019 Apr 15. pii: 2730953. doi: 10.1001/jama.2019.3471.
    PubMed     Text format    


  29. YANO Y, Muntner P, Lloyd-Jones D
    Hypertension in Young Adults and Subsequent Cardiovascular Disease-Reply.
    JAMA. 2019;321:1310-1311.
    PubMed     Text format    


  30. DE KOUCHKOVSKY I, Mayfield J, Kohlwes J
    Hypertension in Young Adults and Subsequent Cardiovascular Disease.
    JAMA. 2019;321:1310.
    PubMed     Text format    


    March 2019
  31. ZHONG VW, Van Horn L, Cornelis MC, Wilkins JT, et al
    Associations of Dietary Cholesterol or Egg Consumption With Incident Cardiovascular Disease and Mortality.
    JAMA. 2019;321:1081-1095.
    PubMed     Text format     Abstract available


  32. BONOW RO, Braunwald E
    The Evidence Supporting Cardiovascular Guidelines: Is There Evidence of Progress in the Last Decade?
    JAMA. 2019;321:1053-1054.
    PubMed     Text format    


  33. ECKEL RH
    Reconsidering the Importance of the Association of Egg Consumption and Dietary Cholesterol With Cardiovascular Disease Risk.
    JAMA. 2019;321:1055-1056.
    PubMed     Text format    


    February 2019
  34. HANEUSE S, VanderWeele TJ, Arterburn D
    Using the E-Value to Assess the Potential Effect of Unmeasured Confounding in Observational Studies.
    JAMA. 2019;321:602-603.
    PubMed     Text format    


    January 2019
  35. FERENCE BA, Kastelein JJP, Ray KK, Ginsberg HN, et al
    Association of Triglyceride-Lowering LPL Variants and LDL-C-Lowering LDLR Variants With Risk of Coronary Heart Disease.
    JAMA. 2019;321:364-373.
    PubMed     Text format     Abstract available


  36. NAVAR AM
    The Evolving Story of Triglycerides and Coronary Heart Disease Risk.
    JAMA. 2019;321:347-349.
    PubMed     Text format    


  37. ZHENG SL, Roddick AJ
    Association of Aspirin Use for Primary Prevention With Cardiovascular Events and Bleeding Events: A Systematic Review and Meta-analysis.
    JAMA. 2019;321:277-287.
    PubMed     Text format     Abstract available


  38. MCCARTNEY PJ, Eteiba H, Maznyczka AM, McEntegart M, et al
    Effect of Low-Dose Intracoronary Alteplase During Primary Percutaneous Coronary Intervention on Microvascular Obstruction in Patients With Acute Myocardial Infarction: A Randomized Clinical Trial.
    JAMA. 2019;321:56-68.
    PubMed     Text format     Abstract available


  39. WANG TY, Kaltenbach LA, Cannon CP, Fonarow GC, et al
    Effect of Medication Co-payment Vouchers on P2Y12 Inhibitor Use and Major Adverse Cardiovascular Events Among Patients With Myocardial Infarction: The ARTEMIS Randomized Clinical Trial.
    JAMA. 2019;321:44-55.
    PubMed     Text format     Abstract available


  40. JACKEVICIUS CA, Ko DT
    Medication Co-payment Vouchers, Adherence With Antiplatelet Therapy, and Adverse Cardiovascular Events After Myocardial Infarction.
    JAMA. 2019;321:37-39.
    PubMed     Text format    


    December 2018
  41. LOTTA LA, Wittemans LBL, Zuber V, Stewart ID, et al
    Association of Genetic Variants Related to Gluteofemoral vs Abdominal Fat Distribution With Type 2 Diabetes, Coronary Disease, and Cardiovascular Risk Factors.
    JAMA. 2018;320:2553-2563.
    PubMed     Text format     Abstract available


  42. WADHERA RK, Joynt Maddox KE, Wasfy JH, Haneuse S, et al
    Association of the Hospital Readmissions Reduction Program With Mortality Among Medicare Beneficiaries Hospitalized for Heart Failure, Acute Myocardial Infarction, and Pneumonia.
    JAMA. 2018;320:2542-2552.
    PubMed     Text format     Abstract available


  43. FONAROW GC
    Unintended Harm Associated With the Hospital Readmissions Reduction Program.
    JAMA. 2018;320:2539-2541.
    PubMed     Text format    


  44. SAMIERI C, Empana JP
    Cardiovascular Health and Cognitive Decline-Reply.
    JAMA. 2018;320:2483-2484.
    PubMed     Text format    


  45. HOWLAND RH
    Cardiovascular Health and Cognitive Decline.
    JAMA. 2018;320:2483.
    PubMed     Text format    


    November 2018
  46. KIM JM, Stewart R, Yoon JS
    Cardiac Outcomes After Treatment for Depression in Patients With Acute Coronary Syndrome-Reply.
    JAMA. 2018;320:2152-2153.
    PubMed     Text format    


  47. RUST G
    Cardiac Outcomes After Treatment for Depression in Patients With Acute Coronary Syndrome.
    JAMA. 2018;320:2152.
    PubMed     Text format    


  48. ZIMMERMANN FM, El Farissi M, Tonino PAL
    Cardiac Outcomes After Treatment for Depression in Patients With Acute Coronary Syndrome.
    JAMA. 2018;320:2151-2152.
    PubMed     Text format    


  49. THOMBS BD, Ziegelstein RC
    Cardiac Outcomes After Treatment for Depression in Patients With Acute Coronary Syndrome.
    JAMA. 2018;320:2151.
    PubMed     Text format    


  50. ROSENSTOCK J, Perkovic V, Johansen OE, Cooper ME, et al
    Effect of Linagliptin vs Placebo on Major Cardiovascular Events in Adults With Type 2 Diabetes and High Cardiovascular and Renal Risk: The CARMELINA Randomized Clinical Trial.
    JAMA. 2018 Nov 9. pii: 2714646. doi: 10.1001/jama.2018.18269.
    PubMed     Text format     Abstract available


  51. VAN SLOTEN TT, Tafflet M, Perier MC, Dugravot A, et al
    Association of Change in Cardiovascular Risk Factors With Incident Cardiovascular Events.
    JAMA. 2018;320:1793-1804.
    PubMed     Text format     Abstract available


  52. SON JS, Choi S, Kim K, Kim SM, et al
    Association of Blood Pressure Classification in Korean Young Adults According to the 2017 American College of Cardiology/American Heart Association Guidelines With Subsequent Cardiovascular Disease Events.
    JAMA. 2018;320:1783-1792.
    PubMed     Text format     Abstract available


  53. YANO Y, Reis JP, Colangelo LA, Shimbo D, et al
    Association of Blood Pressure Classification in Young Adults Using the 2017 American College of Cardiology/American Heart Association Blood Pressure Guideline With Cardiovascular Events Later in Life.
    JAMA. 2018;320:1774-1782.
    PubMed     Text format     Abstract available


  54. VASAN RS
    High Blood Pressure in Young Adulthood and Risk of Premature Cardiovascular Disease: Calibrating Treatment Benefits to Potential Harm.
    JAMA. 2018;320:1760-1763.
    PubMed     Text format    


    October 2018
  55. SLOMSKI A
    No Cardiovascular Protection From Omega-3 Fatty Acids.
    JAMA. 2018;320:1631.
    PubMed     Text format    


  56. ABBASI J
    To Prevent Cardiovascular Disease, Pay Attention to Pregnancy Complications.
    JAMA. 2018 Oct 17. pii: 2708197. doi: 10.1001/jama.2018.14645.
    PubMed     Text format    


  57. VOELKER R
    Device Approved to Seal Coronary Artery Perforations.
    JAMA. 2018;320:1528.
    PubMed     Text format    


  58. FISHER DP, Johnson E, Haneuse S, Arterburn D, et al
    Association Between Bariatric Surgery and Macrovascular Disease Outcomes in Patients With Type 2 Diabetes and Severe Obesity.
    JAMA. 2018;320:1570-1582.
    PubMed     Text format     Abstract available


  59. ABBASI J
    Researchers Test New Techniques to Rule Out and Predict Heart Attacks.
    JAMA. 2018;320:1425.
    PubMed     Text format    


    September 2018
  60. BHATT DL
    Fractional Flow Reserve Measurement for the Physiological Assessment of Coronary Artery Stenosis Severity.
    JAMA. 2018;320:1275-1276.
    PubMed     Text format    


  61. FRIEDRICH MJ
    Cardiovascular Disease in India.
    JAMA. 2018;320:1097.
    PubMed     Text format    


  62. ZHU Y, Zhao Q
    Antiplatelet Therapy After Coronary Artery Bypass Grafting-Reply.
    JAMA. 2018;320:1036-1037.
    PubMed     Text format    


  63. SHAH R, Hesterberg K
    Antiplatelet Therapy After Coronary Artery Bypass Grafting.
    JAMA. 2018;320:1035.
    PubMed     Text format    


  64. MORI M, Geirsson A
    Antiplatelet Therapy After Coronary Artery Bypass Grafting.
    JAMA. 2018;320:1035-1036.
    PubMed     Text format    


  65. WRIGHT JS, Wall HK, Ritchey MD
    Million Hearts 2022: Small Steps Are Needed for Cardiovascular Disease Prevention.
    JAMA. 2018 Sep 6. pii: 2702070. doi: 10.1001/jama.2018.13326.
    PubMed     Text format    


    August 2018
  66. WILLIAMSON W, Lewandowski AJ, Forkert ND, Griffanti L, et al
    Association of Cardiovascular Risk Factors With MRI Indices of Cerebrovascular Structure and Function and White Matter Hyperintensities in Young Adults.
    JAMA. 2018;320:665-673.
    PubMed     Text format     Abstract available


  67. SAMIERI C, Perier MC, Gaye B, Proust-Lima C, et al
    Association of Cardiovascular Health Level in Older Age With Cognitive Decline and Incident Dementia.
    JAMA. 2018;320:657-664.
    PubMed     Text format     Abstract available


  68. SAVER JL, Cushman M
    Striving for Ideal Cardiovascular and Brain Health: It Is Never Too Early or Too Late.
    JAMA. 2018;320:645-647.
    PubMed     Text format    


    July 2018
  69. DONADINI MP, Bellesini M, Squizzato A
    Aspirin Plus Clopidogrel vs Aspirin Alone for Preventing Cardiovascular Events Among Patients at High Risk for Cardiovascular Events.
    JAMA. 2018 Jul 26. pii: 2695067. doi: 10.1001/jama.2018.9641.
    PubMed     Text format     Abstract available


  70. KIM JM, Stewart R, Lee YS, Lee HJ, et al
    Effect of Escitalopram vs Placebo Treatment for Depression on Long-term Cardiac Outcomes in Patients With Acute Coronary Syndrome: A Randomized Clinical Trial.
    JAMA. 2018;320:350-358.
    PubMed     Text format     Abstract available


  71. RUBIN R
    Red Meat Allergy Associated With Coronary Artery Plaque.
    JAMA. 2018;320:331.
    PubMed     Text format    


  72. JIN J
    Risk Assessment for Cardiovascular Disease With Nontraditional Risk Factors.
    JAMA. 2018;320:316.
    PubMed     Text format    


  73. WILKINS JT, Lloyd-Jones DM
    USPSTF Recommendations for Assessment of Cardiovascular Risk With Nontraditional Risk Factors: Finding the Right Tests for the Right Patients.
    JAMA. 2018 Jul 10. pii: 2687223. doi: 10.1001/jama.2018.9346.
    PubMed     Text format    


  74. CURRY SJ, Krist AH, Owens DK, Barry MJ, et al
    Screening for Peripheral Artery Disease and Cardiovascular Disease Risk Assessment With the Ankle-Brachial Index: US Preventive Services Task Force Recommendation Statement.
    JAMA. 2018;320:177-183.
    PubMed     Text format     Abstract available


  75. LIN JS, Evans CV, Johnson E, Redmond N, et al
    Nontraditional Risk Factors in Cardiovascular Disease Risk Assessment: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force.
    JAMA. 2018 Jul 10. pii: 2687224. doi: 10.1001/jama.2018.4242.
    PubMed     Text format     Abstract available


  76. CURRY SJ, Krist AH, Owens DK, Barry MJ, et al
    Risk Assessment for Cardiovascular Disease With Nontraditional Risk Factors: US Preventive Services Task Force Recommendation Statement.
    JAMA. 2018 Jul 10. pii: 2687225. doi: 10.1001/jama.2018.8359.
    PubMed     Text format     Abstract available


    June 2018
  77. SELAK V, Kerr A, Poppe K, Wu B, et al
    Annual Risk of Major Bleeding Among Persons Without Cardiovascular Disease Not Receiving Antiplatelet Therapy.
    JAMA. 2018;319:2507-2520.
    PubMed     Text format     Abstract available


  78. JONAS DE, Reddy S, Middleton JC, Barclay C, et al
    Screening for Cardiovascular Disease Risk With Resting or Exercise Electrocardiography: Evidence Report and Systematic Review for the US Preventive Services Task Force.
    JAMA. 2018;319:2315-2328.
    PubMed     Text format     Abstract available


  79. CURRY SJ, Krist AH, Owens DK, Barry MJ, et al
    Screening for Cardiovascular Disease Risk With Electrocardiography: US Preventive Services Task Force Recommendation Statement.
    JAMA. 2018;319:2308-2314.
    PubMed     Text format     Abstract available


  80. JIN J
    Screening for Cardiovascular Disease Risk With ECG.
    JAMA. 2018;319:2346.
    PubMed     Text format    


  81. MCCARTHY CP, Vaduganathan M, Januzzi JL Jr
    Type 2 Myocardial Infarction-Diagnosis, Prognosis, and Treatment.
    JAMA. 2018 Jun 11. pii: 2684931. doi: 10.1001/jama.2018.7125.
    PubMed     Text format    


  82. MERCHANT FM, Dickert NW Jr, Howard DH
    Mandatory Shared Decision Making by the Centers for Medicare & Medicaid Services for Cardiovascular Procedures and Other Tests.
    JAMA. 2018 Jun 4. pii: 2683805. doi: 10.1001/jama.2018.6617.
    PubMed     Text format    


    May 2018
  83. BHATT DL
    Percutaneous Coronary Intervention in 2018.
    JAMA. 2018;319:2127-2128.
    PubMed     Text format    


  84. ABBASI J
    Another Nail in the Coffin for Fish Oil Supplements.
    JAMA. 2018;319:1851-1852.
    PubMed     Text format    


    April 2018
  85. ZHAO Q, Zhu Y, Xu Z, Cheng Z, et al
    Effect of Ticagrelor Plus Aspirin, Ticagrelor Alone, or Aspirin Alone on Saphenous Vein Graft Patency 1 Year After Coronary Artery Bypass Grafting: A Randomized Clinical Trial.
    JAMA. 2018;319:1677-1686.
    PubMed     Text format     Abstract available


  86. ALEXANDER JH
    Ticagrelor Following Coronary Artery Bypass Grafting: For Better Vein Graft Patency or Better Patient Outcomes?
    JAMA. 2018;319:1661-1662.
    PubMed     Text format    


  87. NAVARESE EP, Robinson JG, Kowalewski M, Kolodziejczak M, et al
    Association Between Baseline LDL-C Level and Total and Cardiovascular Mortality After LDL-C Lowering: A Systematic Review and Meta-analysis.
    JAMA. 2018;319:1566-1579.
    PubMed     Text format     Abstract available


  88. ABBASI J
    Using Heart Pump Data to Manage Cardiogenic Shock.
    JAMA. 2018;319:1427.
    PubMed     Text format    


  89. YU K, Qiu G, Chan KH, Lam KH, et al
    Association of Solid Fuel Use With Risk of Cardiovascular and All-Cause Mortality in Rural China.
    JAMA. 2018;319:1351-1361.
    PubMed     Text format     Abstract available


    March 2018
  90. GUPTA A, Das SR, Pandey A
    beta-Blockers in Myocardial Infarction: Issues With Standard Admission Order Sets.
    JAMA. 2018;319:1269-1270.
    PubMed     Text format    


  91. BERWANGER O, Santucci EV, de Barros E Silva PGM, Jesuino IA, et al
    Effect of Loading Dose of Atorvastatin Prior to Planned Percutaneous Coronary Intervention on Major Adverse Cardiovascular Events in Acute Coronary Syndrome: The SECURE-PCI Randomized Clinical Trial.
    JAMA. 2018 Mar 11. pii: 2675023. doi: 10.1001/jama.2018.2444.
    PubMed     Text format     Abstract available


  92. NICHOLLS SJ, Psaltis PJ
    Lipid Lowering in Acute Coronary Syndrome: Is Treatment Early Enough?
    JAMA. 2018 Mar 11. pii: 2675022. doi: 10.1001/jama.2018.2426.
    PubMed     Text format    


  93. ABBASI J
    Do All Patients Need beta-Blockers After a Heart Attack?
    JAMA. 2018;319:853-855.
    PubMed     Text format    


    February 2018
  94. HUFFMAN MD, Mohanan PP, Devarajan R, Baldridge AS, et al
    Effect of a Quality Improvement Intervention on Clinical Outcomes in Patients in India With Acute Myocardial Infarction: The ACS QUIK Randomized Clinical Trial.
    JAMA. 2018;319:567-578.
    PubMed     Text format     Abstract available


    January 2018
  95. WADHERA RK, Yeh RW, Joynt Maddox KE
    The Rise and Fall of Mandatory Cardiac Bundled Payments.
    JAMA. 2018;319:335-336.
    PubMed     Text format    


  96. KENNEDY AB, Lavie CJ, Blair SN
    Fitness or Fatness: Which Is More Important?
    JAMA. 2018;319:231-232.
    PubMed     Text format    


    December 2017
  97. GREENLAND P
    Cardiovascular Guideline Skepticism vs Lifestyle Realism?
    JAMA. 2017 Dec 14. pii: 2666625. doi: 10.1001/jama.2017.19675.
    PubMed     Text format    


    November 2017
  98. SLOMSKI A
    Evolocumab Reduces Cardiovascular Risk Regardless of Diabetes Status.
    JAMA. 2017;318:1968.
    PubMed     Text format    


  99. EMDIN CA, Khera AV, Kathiresan S
    Mendelian Randomization.
    JAMA. 2017;318:1925-1926.
    PubMed     Text format    


  100. IRONY TZ
    The "Utility" in Composite Outcome Measures: Measuring What Is Important to Patients.
    JAMA. 2017;318:1820-1821.
    PubMed     Text format    


  101. CHAPMAN AR, Lee KK, McAllister DA, Cullen L, et al
    Association of High-Sensitivity Cardiac Troponin I Concentration With Cardiac Outcomes in Patients With Suspected Acute Coronary Syndrome.
    JAMA. 2017 Nov 11. doi: 10.1001/jama.2017.17488.
    PubMed     Text format     Abstract available


    October 2017
  102. ABBASI J
    Could a New Method to Detect Coronary Inflammation Prevent Heart Attacks?
    JAMA. 2017;318:1527-1528.
    PubMed     Text format    


    September 2017
  103. WADHERA RK, Bhatt DL
    Taking the "Public" Out of Public Reporting of Percutaneous Coronary Intervention.
    JAMA. 2017 Sep 28. doi: 10.1001/jama.2017.12087.
    PubMed     Text format    


  104. LICHTMAN JH, Jones MR, Leifheit EC, Sheffet AJ, et al
    Carotid Endarterectomy and Carotid Artery Stenting in the US Medicare Population, 1999-2014.
    JAMA. 2017;318:1035-1046.
    PubMed     Text format     Abstract available


  105. BARNARD ND, Willett WC, Ding EL
    The Misuse of Meta-analysis in Nutrition Research.
    JAMA. 2017 Sep 18. doi: 10.1001/jama.2017.12083.
    PubMed     Text format    


  106. DEVEREAUX PJ, Biccard BM, Chan MTV
    High-Sensitivity Troponin Levels, Ischemia, and Mortality-Reply.
    JAMA. 2017;318:865.
    PubMed     Text format    


  107. SMILOWITZ NR
    High-Sensitivity Troponin Levels, Ischemia, and Mortality.
    JAMA. 2017;318:864-865.
    PubMed     Text format    


    August 2017
  108. KRUMHOLZ HM
    Treatment of Cholesterol in 2017.
    JAMA. 2017;318:417-418.
    PubMed     Text format    


Thank you for your interest in scientific medicine.


AMEDEO Ischemic Heart Disease is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: